TipRanks
Pharming Group (PHAR)
NASDAQ:PHAR
Want to see PHAR full AI Analyst Report?

Compare Pharming Group (PHAR) vs. Competitors

240 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Pharming Group
$11.77
$684.02M
64.47
-33.68%
2 Buy
0 Hold
0 Sell
Moderate Buy
Trevi Therapeutics
$13.47
$1.87B
-37.97
30.60%
10 Buy
0 Hold
0 Sell
Strong Buy
Oric Pharmaceuticals
$13.83
$1.24B
-8.91
-15.76%
9 Buy
0 Hold
0 Sell
Strong Buy
Praxis Precision Medicines
$377.37
$7.76B
-20.35
385.45%
14 Buy
1 Hold
0 Sell
Strong Buy
ARS Pharmaceuticals
$5.72
$433.59M
-2.09
-58.96%
3 Buy
0 Hold
0 Sell
Strong Buy
Prime Medicine, Inc.
$3.58
$707.37M
-3.25
-44.50%
7 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PHAR
Pharming Group
9.53
-5.06
-34.67%
TRVI
Trevi Therapeutics
12.83
2.90
29.28%
ORIC
Oric Pharmaceuticals
12.03
-2.05
-14.56%
PRAX
Praxis Precision Medicines
263.55
208.79
381.28%
SPRY
ARS Pharmaceuticals
4.56
-7.02
-60.62%
PRME
Prime Medicine, Inc.
3.58
-2.65
-42.54%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts